Cinaciguat
Cinaciguat
|
Clinical data |
---|
Routes of administration |
intravenous (?) |
---|
ATC code |
none |
---|
Identifiers |
---|
- 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)
phenyl]methoxy}phenyl)ethyl]amino}methyl) benzoic acid
|
CAS Number |
329773-35-5 Y |
---|
PubChem (CID) |
9808022 |
---|
IUPHAR/BPS |
5168 |
---|
ChemSpider |
7983781 N |
---|
UNII |
59K0Y58UAD Y |
---|
Chemical and physical data |
---|
Formula |
C36H39NO5 |
---|
Molar mass |
565.697 g/mol |
---|
3D model (Jmol) |
Interactive image |
---|
c4ccccc4CCc3ccc(cc3)COc1ccccc1CCN(CCCCC(O)=O)Cc2ccc(C(=O)O)cc2
|
InChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41) NKey:WPYWMXNXEZFMAK-UHFFFAOYSA-N N
|
NY (what is this?) (verify) |
---|
Cinaciguat (BAY 58-2667) is an experimental drug for the treatment of acute decompensated heart failure.
Mechanism of action
Cinaciguat activates the soluble guanylate cyclase (sGC) which is a receptor for nitric oxide. This increases biosynthesis of cyclic GMP, resulting in vasodilation.[1]
See also
- Riociguat, another drug stimulating sGC, but with a different mechanism
- PDE5 inhibitors act further downstream in the nitric oxide signalling pathway, reducing cyclic GMP degradation.
References
- ↑ Schubert-Zsilavecz, M, Wurglics, M, Neue Arzneimittel 2009
|
---|
|
Forms | |
---|
|
Targets | |
---|
|
NO donors (prodrugs) |
- NONOates (diazeniumdiolates): Diethylamine/NO (DEA/NO)
- Diethylenetriamine/NO (DETA/NO)
- GLO/NO
- JS-K
- Methylamine hexamethylene methylamine/NO (MAHMA/NO)
- PROLI/NO
- Spermine/NO (SPER/NO)
- V-PYRRO/NO
- Unsorted: CXL-1427
- FK-409
- FR144220
- FR146881
- N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide
|
---|
|
Enzyme (inhibitors) | NOS | nNOS | |
---|
| iNOS |
- 1-Amino-2-hydroxyguanidine
- 2-Ethylaminoguanidine
- 2-Iminopiperidine
- 1400W
- AEITU
- Aminoguanidine (pimagedine)
- AMT
- AR-C 102222
- BYK-191023
- Canavanine
- Cindunistat (SD-6010)
- EITU
- IPTU
- MITU
- N5-(1-Iminoethyl)-L-ornithine (L-NIO)
- N6-(1-Iminoethyl)-L-lysine (L-NIL)
- Nω-Methyl-L-arginine (L-NMA)
- Ronopterin (VAS-203)
- TRIM
|
---|
| eNOS | |
---|
| Unsorted |
- Asymmetric dimethylarginine (ADMA)
- CKD-712
- Guanidinoethyldisulfide (GED)
- GW-273629
- Indospicine
- KD-7040
- Nitroarginine methyl ester (NAME)
- NCX-456
- NXN-462
- ONO-1714
- VAS-2381
|
---|
|
---|
| Arginase |
- ABH
- Nω-Hydroxy-L-arginine (NOHA)
|
---|
| CAMK | |
---|
|
---|
|
Others |
- Precursors: L-Arginine
- Nω-Hydroxy-L-arginine (NOHA)
|
---|